This educational activity is designed to address the clinical and operational challenges community oncology clinicians face as EGFR-mutated NSCLC care becomes increasingly complex across the disease continuum. By strengthening clinicians ability to implement timely molecular testing, apply evolving evidence from key EGFR-directed trials, individualize first-line and post-progression treatment strategies, recognize resistance mechanisms, and navigate real-world care coordination barriers, the program will support more consistent translation of current standards into routine practice. For community clinicians caring for patients with EGFR-mutated NSCLC, this education will emphasize practical strategies for aligning treatment decisions with clinical evidence, patient-specific factors, access considerations, and multidisciplinary care pathways. Ultimately, through faculty-led didactic presentations, case-based scenarios, and expert discussion, the activity aims to improve clinician readiness to deliver timely, biomarker-informed, and patient-centered EGFR-directed care across varied practice settings.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Pricing
All courses included · from $18.75/mo
Courses are included in the subscription; some are also sold individually.
| Student Flex | $18.75/mo |
| Professional Flex | $60/mo |
| Student 3-Year | $100 |
| Student 2-Year | $112.50 |
+4 more plans
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Maternal-Fetal Medicine
- Medical Leadership & Administration
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Surgical Oncology
- Thoracic Anesthesia
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Live
- Credit · Up to 1 credit
- Commercial Support
-
WhenOct 16 – Dec 31, 2026
-
Medscape, LLC Autumn Updates: Exploring Innovations in EGFR-Mutated NSCLC
-
PRIME Education, Inc. (PRIME®) Clinical Momentum: Advancements for Menin Inhibitors in NPM1-Mutated AML
-
Clinical Care Options, LLC (dba Decera Clinical Education) Management of a Patient With EGFR-Mutated NSCLC and Brain Metastases
-
Plexus Communications +1 Targeting EGFR in NSCLC: Evidence-Based Strategies Across Stages, Sequencing, and Resistance in Veterans Health Administration Practice Settings
-
Plexus Communications +1 New Horizons in NSCLC: The Role of ADCs in Enhancing Personalized Care in HER2-Altered Disease 2026
-
Plexus Communications +1 Transforming Care in Pancreatic Ductal Adenocarcinoma: Emerging Evidence and Clinical Implications
